Groupama Asset Managment »

Sarepta Therapeutics shares owned by Groupama Asset Managment

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Groupama Asset Managment from 13F filings

Historical chart of Groupama Asset Managment investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Groupama Asset Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Groupama Asset Managment

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 1.3M 0.91

More positions owned by Groupama Asset Managment

Microsoft Corporation (MSFT)
Alnylam Pharmaceuticals (ALNY)
Cyberark Software SHS (CYBR)
Mongodb Cl A (MDB)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Insulet Corporation (PODD)
Akamai Technologies (AKAM)
Dex (DXCM)
Broadcom (AVGO)
Zscaler Incorporated (ZS)
Palo Alto Networks (PANW)
Alphabet Cap Stk Cl A (GOOGL)
Datadog Cl A Com (DDOG)
Amazon (AMZN)

View all positions for Groupama Asset Managment

Top funds holding Sarepta Therapeutics

BlackRock
Capital Research and Management Company - Division 3
Jpmorgan Chase & Co
Bank of New York Mellon
T. Rowe Price Investment Management
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Citadel Advisors
Groupama Asset Managment
Casdin Capital
Pictet Asset Management Holding SA
OrbiMed Advisors
Susquehanna International
Bank of America Corporation
Jacobs Levy Equity Management

View all funds holding Sarepta Therapeutics